{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:55:07Z","timestamp":1787813707083,"version":"build-2784847793"},"reference-count":173,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007928","name":"University of Pennsylvania Perelman School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijwd.2021.08.015","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T04:56:32Z","timestamp":1631163392000},"page":"560-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"PA","title":["Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis"],"prefix":"10.1097","volume":"7","author":[{"given":"Emily","family":"Keyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-5185","authenticated-orcid":false,"given":"Madison","family":"Grinnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1721-5617","authenticated-orcid":false,"given":"Thomas","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-0212","authenticated-orcid":false,"given":"DeAnna","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-5369","authenticated-orcid":false,"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Jon","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2021.08.015_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3972706","article-title":"High prevalence of metabolic syndrome in patients with discoid lupus erythematosus: A cross-sectional, case-control study","volume":"2017","author":"Akarsu","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ahj.2017.10.026","article-title":"Factors of health in the protection against death and cardiovascular disease among adults with subclinical atherosclerosis","volume":"198","author":"Al Rifai","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0004","doi-asserted-by":"crossref","first-page":"20303","DOI":"10.1038\/srep20303","article-title":"The prevalence of atherosclerosis in those with inflammatory connective tissue disease by race, age, and traditional risk factors","volume":"6","author":"Alenghat","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/367359","article-title":"Cardiovascular involvement in autoimmune diseases","volume":"2014","author":"Amaya-Amaya","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0006","unstructured":"American College of Cardiology. ASCVD risk estimator plus [Internet]. 2021 [cited 2021 June 12]. Available from: https:\/\/tools.acc.org\/ascvd-risk-estimator-plus\/#!\/calculate\/estimate\/."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0007","first-page":"140","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0008","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0009","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/clc.23375","article-title":"Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study","volume":"43","author":"Bae","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0010","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0012","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.22343","article-title":"Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study","volume":"55","author":"Bessant","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2016.01.001","article-title":"Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy","volume":"207","author":"Booth","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0016","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: A triumph of simplicity","volume":"27","author":"Bor\u00e9n","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0018","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study: Coronary risk factors in women with SLE","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0019","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: Final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0020","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week","volume":"76","author":"Cainzos-Achirica","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11926-010-0100-7","article-title":"Cutaneous manifestations of dermatomyositis and their management","volume":"12","author":"Callen","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0022","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0024","first-page":"2017","article-title":"Aggressive and fatal statin-induced dermatomyositis: A case report","author":"Chemello","year":"2017","journal-title":"Oxf Med Case Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0025","unstructured":"Chilazi M, Sharma G, Arvanitis M, Leucker T, Blumenthal R, Martin S. Novel therapies to know for ASCVD prevention in 2021 and beyond [Internet]. 2021 [cited 2021 June 12]. Available from: https:\/\/www.healio.com\/news\/cardiology\/20210330\/novel-therapies-to-know-for-ascvd-prevention-in-2021-and-beyond"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0026","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00296-007-0341-6","article-title":"A pravastatin dose-escalation study in systemic lupus erythematosus","volume":"27","author":"Costenbader","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0027","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00129784-200303010-00007","volume":"3","author":"Darkes","year":"2003","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0028","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00296-015-3316-z","article-title":"Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: Association with disease activity, nephritis, smoking, and age","volume":"36","author":"das Chagas Medeiros","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0029","first-page":"I19","article-title":"Anatomic features in victims of sudden coronary death. Coronary artery pathology","volume":"85","author":"Davies","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/acr.21879","article-title":"Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease: Metabolic syndrome and CVD in DM","volume":"65","author":"de Moraes","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0961203307087612","article-title":"Lupus: Improving long-term prognosis","volume":"17","author":"Doria","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6820","article-title":"Association between bariatric surgery and major adverse diabetes outcomes in patients with diabetes and obesity","volume":"4","author":"Doumouras","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0033","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0034","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0961203314537696","article-title":"The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients","volume":"23","author":"Eder","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000272","article-title":"QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus","volume":"5","author":"Edwards","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0036","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/jama.1953.03690120006002","article-title":"Coronary disease among United States soldiers killed in action in Korea: Preliminary report","volume":"152","author":"Enos","year":"1953","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0037","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0038","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0039","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","article-title":"Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) study","volume":"131","author":"Fern\u00e1ndez-Friera","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpba.2019.06.005","article-title":"Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus","volume":"174","author":"Ferreira","year":"2019","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0041","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis: Inflammatory myopathies","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0042","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/2047487314525531","article-title":"What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice","volume":"21","author":"Finegold","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0043","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0044","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaccas.2019.12.019","article-title":"Statin-induced necrotizing autoimmune myopathy","volume":"2","author":"Gawey","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib9903","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/096120339700600908","article-title":"Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies","volume":"6","author":"George","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7326\/0003-4819-142-1-200501040-00112","article-title":"Vitamin E supplements: Good in theory, but is the theory good?","volume":"142","author":"Greenberg","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0046","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.jacc.2007.05.055","article-title":"Time to end the mixed\u2014and often incorrect\u2014messages about prevention and treatment of atherosclerotic cardiovascular disease","volume":"50","author":"Greenland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0047","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.ATV.19.2.442","article-title":"Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model: Interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis","volume":"19","author":"Gu","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0048","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/08820139.2019.1567534","article-title":"A meta-analysis of cardiovascular events in systemic lupus erythematosus","volume":"48","author":"Gu","year":"2019","journal-title":"Immunol Invest"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0049","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10067-020-05257-3","article-title":"Cutaneous lupus erythematosus and cardiovascular disease: Current knowledge and insights into pathogenesis","volume":"40","author":"Guo","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0050","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","volume":"389","author":"Gupta","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0051","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaad.2020.12.013","article-title":"Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study","volume":"84","author":"Haugaard","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0052","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ahj.2018.11.005","article-title":"Accelerated coronary atherosclerosis not explained by traditional risk factors in 13% of young individuals","volume":"208","author":"Head","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0053","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/ATVBAHA.115.306442","article-title":"Nonstatin low-density lipoprotein-lowering therapy and cardiovascular risk reduction\u2014Statement From ATVB Council","volume":"35","author":"Hegele","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.08.015_bib0169","first-page":"70911","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus ery- thematosus and lupus nephritis: a Danish nationwide population-based cohort study","volume":"56","author":"Hermansen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0054","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0961203316651739","article-title":"Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: A Danish nationwide cohort study","volume":"26","author":"Hesselvig","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0055","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0056","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.1780261208","article-title":"Mortality from polymyositis and dermatomyositis in the United States, 1968\u20131978","volume":"26","author":"Hochberg","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0057","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0059","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/03009742.2019.1707281","article-title":"Incidence, survival, and risk of cardiovascular events in adult inflammatory myopathies in South Korea: A nationwide population-based study","volume":"49","author":"Jung","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0061","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjcard.2013.05.040","article-title":"Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus","volume":"112","author":"Kao","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0062","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(17)30752-3","article-title":"Coronary atherosclerosis in indigenous South-American Tsimane: A cross-sectional cohort study","volume":"389","author":"Kaplan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0063","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMe1814004","article-title":"FISHing for the miracle of eicosapentaenoic acid","volume":"380","author":"Kastelein","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0064","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp1614154","article-title":"Oligonucleotide therapeutics\u2014A new class of cholesterol-lowering drugs","volume":"376","author":"Khvorova","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib9902","doi-asserted-by":"crossref","first-page":"H646","DOI":"10.1152\/ajpheart.00787.2014","article-title":"Splenic autonomic denervation increases inflammatory status but does not aggravate atherosclerotic lesion development","volume":"309","author":"Kooijman","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2015.12.056","article-title":"Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium","volume":"67","author":"Laclaustra","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0066","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clinbiochem.2004.10.006","article-title":"Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus","volume":"38","author":"Lagogianni","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0067","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bjd.12245","article-title":"Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: A Taiwanese population-based longitudinal follow-up study: Dermatomyositis and ischaemic stroke","volume":"168","author":"Lai","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0068","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjmed.2021.02.029","article-title":"Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease","volume":"134","author":"Lee","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib9901","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/CIRCRESAHA.111.246702","article-title":"Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation","volume":"109","author":"Levin","year":"2011","journal-title":"Circ Res."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0069","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.semarthrit.2020.08.009","article-title":"Mortality trends in polymyositis and dermatomyositis: A general population-based study","volume":"50","author":"Li","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2021.08.015_bib9904","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/bs.acc.2016.06.005","article-title":"Microvesicles in autoimmune diseases","volume":"77","author":"Liu","year":"2016","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.0000254674.47693.e8","article-title":"Cholesterol enrichment of human monocyte\/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles","volume":"27","author":"Liu","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0071","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodr\u00e1","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0072","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/CIR.0b013e31825719f3","article-title":"Periodontal disease and atherosclerotic vascular disease: Does the evidence support an independent association? A scientific statement from the American Heart Association","volume":"125","author":"Lockhart","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0073","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/kel311","article-title":"The heart in dermatomyositis and polymyositis","volume":"45","author":"Lundberg","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0074","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2008.01.002","article-title":"Accelerated atherosclerosis in ApoE deficient lupus mouse models","volume":"127","author":"Ma","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0076","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.CIR.94.5.928","article-title":"Vulnerable plaque: Relation of characteristics to degree of stenosis in human coronary arteries","volume":"94","author":"Mann","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0077","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0078","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1074\/jbc.273.7.4081","article-title":"Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase","volume":"273","author":"Marathe","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0079","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10067-019-04856-z","article-title":"Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies","volume":"39","author":"Masson","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jama.298.3.336","article-title":"Triglycerides and risk for coronary heart disease","volume":"298","author":"McBride","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0081","unstructured":"McKee S. Novartis pulls EU filing for canakinumab [Internet]. 2018 [cited 2021 June 12]. Available from: http:\/\/www.pharmatimes.com\/news\/novartis_pulls_eu_filing_for_canakinumab_1272906."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0082","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archinte.165.8.883","article-title":"Risk scores predict atherosclerotic lesions in young people","volume":"165","author":"McMahan","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0083","unstructured":"Multi-ethnic Study of Atherosclerosis. MESA 10-year CHD risk with CAC [Internet]. 2021 [cited 2021 June 12]. Available from: https:\/\/mesa-nhlbi.org\/MESACHDRisk\/MesaRiskScore\/RiskScore.aspx."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0084","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.20440","article-title":"Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: A randomized, double-blind, placebo-controlled trial","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0085","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1177\/0961203318790676","article-title":"Incidence of cardiovascular risk factors in female patients with systemic lupus erythematosus: A 3-year follow-up cohort","volume":"27","author":"Mon\u00e7\u00e3o","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102371","article-title":"Mendez Martinez S, et al. Systemic lupus erythematosus and hypertension","volume":"18","author":"Munguia-Realpozo","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0087","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjmed.2015.10.032","article-title":"Trends in coronary atherosclerosis: A tale of two population subgroups","volume":"129","author":"Nemetz","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0088","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0089","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0961203307077987","article-title":"Current causes of death in systemic lupus erythematosus in Europe, 2000\u20132004: Relation to disease activity and damage accrual","volume":"16","author":"Nossent","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0090","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2011.06.032","article-title":"No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease","volume":"9","author":"Osterman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0091","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.118.039415","article-title":"Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (EWTOPIA 75): A randomized, controlled trial","volume":"140","author":"Ouchi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0092","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HCO.0000000000000842","article-title":"Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology","volume":"36","author":"Page","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0093","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ijwd.2021.08.015_bib0094","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","article-title":"Hydroxychloroquine use in the Baltimore lupus cohort: Effects on lipids, glucose and thrombosis","volume":"5","author":"Petri","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0096","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000346","article-title":"Development of a systemic lupus erythematosus cardiovascular risk equation","volume":"6","author":"Petri","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0097","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus atherosclerosis prevention study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0098","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar3402","article-title":"Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: A prospective, randomized, double-masked, placebo-controlled study","volume":"13","author":"Plazak","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0099","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11883-020-00848-6","article-title":"Periodontal inflammation and the risk of cardiovascular disease","volume":"22","author":"Priyamvara","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.13.6.932","article-title":"Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice","volume":"13","author":"Qiao","year":"1993","journal-title":"Arterioscler Thromb J Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0101","unstructured":"QRISK\u00ae3-2018 risk calculator. ClinRisk 2018 [Internet]. 2021 [cited 2021 August 8]. Available from: https:\/\/www.qrisk.org\/three\/."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0103","doi-asserted-by":"crossref","first-page":"kev336","DOI":"10.1093\/rheumatology\/kev336","article-title":"Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: A general population-based study","author":"Rai","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0104","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: A novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.md.0000216817.35937.70","article-title":"Vasculitis in systemic lupus erythematosus: Prevalence and clinical characteristics in 670 patients","volume":"85","author":"Ramos-Casals","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0106","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2019.04.207","article-title":"Accelerated atherosclerotic cardiovascular risk in type 1 diabetes mellitus: Time for a new idea?","volume":"286","author":"Rao","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13075-018-1579-y","article-title":"Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis","volume":"20","author":"Raouf","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0108","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0109","doi-asserted-by":"crossref","first-page":"e61042","DOI":"10.1371\/journal.pone.0061042","article-title":"The effect of mycophenolate mofetil on disease development in the gld.apoE\u2212\/\u2212 mouse model of accelerated atherosclerosis and systemic lupus erythematosus","volume":"8","author":"Richez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0110","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0111","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0112","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0113","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.jacc.2021.03.335","article-title":"Glycated hemoglobin and subclinical atherosclerosis in people without diabetes","volume":"77","author":"Rossello","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0114","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-021-00918-3","article-title":"Lipid lowering drugs: Present status and future developments","volume":"23","author":"Ruscica","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0116","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/eurheartj\/ehy319","article-title":"Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths","volume":"39","author":"Ruuth","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0117","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0118","doi-asserted-by":"crossref","first-page":"18324","DOI":"10.1038\/s41598-020-74579-8","article-title":"Atherosclerotic plaque vulnerability is increased in mouse model of lupus","volume":"10","author":"Santiago-Raber","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0119","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.jacc.2021.04.018","article-title":"Glycated hemoglobin to detect subclinical atherosclerosis in people without diabetes","volume":"77","author":"Santos","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0120","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0121","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0122","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000291","article-title":"Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies","volume":"2","author":"Schwartz","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0123","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1573397115666181126105318","article-title":"Systemic lupus erythematosus and endothelial dysfunction: A close relationship","volume":"15","author":"Sciatti","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0124","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2016.11.003","article-title":"HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients","volume":"255","author":"Scicali","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: Atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0127","first-page":"505","article-title":"Adverse effects of corticosteroids on the cardiovascular system","volume":"16","author":"Sholter","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellsig.2018.12.001","article-title":"Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia","volume":"55","author":"Shrestha","year":"2019","journal-title":"Cell Signal"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0129","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kex465","article-title":"Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in U.S. children: An analysis of the National Inpatient Sample","volume":"57","author":"Silverberg","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0130","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/acr.22892","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in cutaneous lupus erythematosus: A population-based cohort study: Cardiovascular disease risk in cutaneous lupus","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0132","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Sk\u00e5l\u00e9n","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9149(02)02633-4","article-title":"How, when, and why to use apolipoprotein B in clinical practice","volume":"90","author":"Sniderman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0134","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: A narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11886-021-01490-7","article-title":"The use of subclinical atherosclerosis imaging to guide preventive cardiology management","volume":"23","author":"Soni","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0136","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1073\/pnas.0602311103","article-title":"Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus","volume":"103","author":"Stanic","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0137","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/ATVBAHA.115.305874","article-title":"Disturbed laminar blood flow vastly augments lipoprotein retention in the artery wall: A key mechanism distinguishing susceptible from resistant sites","volume":"35","author":"Steffensen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0138","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0139","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000409","article-title":"High-risk coronary plaque in SLE: Low-attenuation non-calcified coronary plaque and positive remodelling index","volume":"7","author":"Stojan","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0140","first-page":"37","article-title":"The natural history of coronary atherosclerosis","volume":"40","author":"Strong","year":"1962","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0141","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.108.182568","article-title":"Free cholesterol accumulation in macrophage membranes activates toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K","volume":"104","author":"Sun","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0142","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0143","doi-asserted-by":"crossref","first-page":"20419","DOI":"10.1016\/S0021-9258(20)80745-5","volume":"268","author":"Tabas","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0144","unstructured":"Tardif JC, Gaudet D. Late-breaking science: Lowering triglycerides with antisense oligonucleotides\u2013Are we making progress? [Internet] 2021 [cited 2021 August 8]. Available from: https:\/\/www.escardio.org\/Congresses-&-Events\/ESC-Congress\/Congress-resources\/Congress-news\/Lowering-triglycerides-with-antisense-oligonucleotides-are-we-making-progress."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0145","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0146","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: Comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0147","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/art.40919","article-title":"Use of proprotein convertase subtilisin\/kexin type 9 inhibitors in statin-associated immune-mediated necrotizing myopathy: A case series","volume":"71","author":"Tiniakou","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0148","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/annrheumdis-2019-216764","article-title":"Impact of the new American College of Cardiology\/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus","volume":"79","author":"Tselios","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0149","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: A systematic review","volume":"43","author":"Tselios","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0151","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3899\/jrheum.150983","article-title":"Modified Framingham risk factor score for systemic lupus erythematosus","volume":"43","author":"Urowitz","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0152","unstructured":"U.S. Food and Drug Administration. Statins: Drug safety communication\u2013FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy [Internet]. 2021 [cited 2021 June 12]. Available from: https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/statins-drug-safety-communication-fda-requests-removal-strongest-warning-against-using-cholesterol."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0153","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.2205","article-title":"The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques","volume":"13","author":"van Gils","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0154","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2021.3055","article-title":"Association of statin treatment with progression of coronary atherosclerotic plaque composition","author":"van Rosendael","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0155","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s10067-014-2561-y","article-title":"Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients","volume":"33","author":"Vincze","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0156","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: A Mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0023","unstructured":"World Health Organization. Cardiovascular diseases [Internet]. 2021 [cited 2021 June 12]. Available from: https:\/\/www.who.int\/health-topics\/cardiovascular-diseases\/#tab=tab_1."},{"key":"10.1016\/j.ijwd.2021.08.015_bib0157","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2011.04437.x","article-title":"Lipid profiles in untreated patients with dermatomyositis","volume":"27","author":"Wang","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0158","series-title":"Atherosclerosis","first-page":"291","article-title":"Apolipoprotein-B: The crucial protein of atherogenic lipoproteins","author":"Williams","year":"2015"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0159","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00075197-200503000-00006","article-title":"Oxidation, lipoproteins, and atherosclerosis: Which is wrong, the antioxidants or the theory?","volume":"8","author":"Williams","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0160","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.0000174795.62387.d3","article-title":"Lipoprotein retention\u2014and clues for atheroma regression","volume":"25","author":"Williams","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0161","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0162","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2016.02.004","article-title":"Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward","volume":"247","author":"Williams","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0163","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0164","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10557-019-06906-9","article-title":"Lipoprotein(a) and atherosclerotic cardiovascular disease: Current understanding and future perspectives","volume":"33","author":"Wu","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1468-3083.2011.04211.x","article-title":"Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients: Risk factors for cardiovascular disease in SLE patients","volume":"26","author":"Yang","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2015.08.030","article-title":"Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study","volume":"243","author":"Yu","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0167","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.4238\/2015.November.18.52","article-title":"Vulnerability of atherosclerotic plaques is associated with type I interferon in a murine model of lupus and atherosclerosis","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.ijwd.2021.08.015_bib0168","doi-asserted-by":"crossref","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: A nationwide follow-up study from Sweden","volume":"7","author":"Z\u00f6ller","year":"2012","journal-title":"PLoS One"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:28:22Z","timestamp":1641565702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647521001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":173,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2352647521001088"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.08.015","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}